However, some patients treated with anti-PD-1 inhibitors also have severe cardiovascular manifestations, such as heart failure (HF), malignant arrhythmias, and death, even though a lower incidence of 0.3–2% has been reported in the literature (7, 8). The gene discussed is PDCD1; the disease is hydrops fetalis.